- Home
- CHPT vs ORIC Comparison
CHPT vs ORIC Comparison
Compare CHPT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHPT
- ORIC
- Stock Information
- Founded
- CHPT 2007
- ORIC 2014
- Country
- CHPT United States
- ORIC United States
- Employees
- CHPT N/A
- ORIC N/A
- Industry
- CHPT Industrial Specialties
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- CHPT Consumer Discretionary
- ORIC Health Care
- Exchange
- CHPT Nasdaq
- ORIC Nasdaq
- Market Cap
- CHPT 321.7M
- ORIC 362.9M
- IPO Year
- CHPT N/A
- ORIC 2020
- Fundamental
- Price
- CHPT $0.68
- ORIC $9.35
- Analyst Decision
- CHPT Hold
- ORIC Strong Buy
- Analyst Count
- CHPT 10
- ORIC 8
- Target Price
- CHPT $1.46
- ORIC $18.83
- AVG Volume (30 Days)
- CHPT 20.6M
- ORIC 2.1M
- Earning Date
- CHPT 06-04-2025
- ORIC 08-11-2025
- Dividend Yield
- CHPT N/A
- ORIC N/A
- EPS Growth
- CHPT N/A
- ORIC N/A
- EPS
- CHPT N/A
- ORIC N/A
- Revenue
- CHPT $407,681,000.00
- ORIC N/A
- Revenue This Year
- CHPT $3.54
- ORIC N/A
- Revenue Next Year
- CHPT $26.21
- ORIC N/A
- P/E Ratio
- CHPT N/A
- ORIC N/A
- Revenue Growth
- CHPT N/A
- ORIC N/A
- 52 Week Low
- CHPT $0.51
- ORIC $3.90
- 52 Week High
- CHPT $2.44
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- CHPT 48.12
- ORIC 62.84
- Support Level
- CHPT $0.67
- ORIC $8.85
- Resistance Level
- CHPT $0.87
- ORIC $9.54
- Average True Range (ATR)
- CHPT 0.07
- ORIC 0.74
- MACD
- CHPT -0.01
- ORIC -0.07
- Stochastic Oscillator
- CHPT 17.11
- ORIC 50.98
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.